Over one‐third of cancer cases and two‐fifths of cancer deaths in southern China are preventable: Insights from the latest representative population‐based cancer registry data and risk factor survey
Xiaolan Wen(Chinese Academy of Medical Sciences & Peking Union Medical College), Shaoming Wang(Shihezi University), Liming Pu(Guangdong Provincial Center for Disease Control and Prevention), Wenqiang Wei(Chinese Academy of Medical Sciences & Peking Union Medical College), Dejian Zhao(Guangdong Provincial Center for Disease Control and Prevention), Ruilin Meng(Guangdong Provincial Center for Disease Control and Prevention), Bingfeng Han(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaojun Xu(Guangzhou Center for Disease Control and Prevention), Ye Wang(Guangdong Provincial Center for Disease Control and Prevention), Li Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Yue Gao(Guangdong Provincial Center for Disease Control and Prevention), Ru Chen(Baylor College of Medicine), Qian Zhu(Chinese Academy of Medical Sciences & Peking Union Medical College), Jiayue Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Ni Xiao(Guangdong Provincial Center for Disease Control and Prevention), Xueyan Zheng(Guangdong Provincial Center for Disease Control and Prevention), Yu Liao(Guangdong Provincial Center for Disease Control and Prevention), Xinmei Lin
Cited by 1
Related Papers
Cancer incidence and mortality in China, 2022
|Journal of the National Cancer Center|2024|2k
Cancer incidence and mortality in China, 2016
|Journal of the National Cancer Center|2022|1.6k
Global patterns of breast cancer incidence and mortality: A population‐based cancer registry data analysis from 2000 to 2020
|Cancer Communications|2021|1.1k
Cancer registration in China and its role in cancer prevention and control
|The Lancet Oncology|2020|501
Global, regional, and national lifetime risks of developing and dying from gastrointestinal cancers in 185 countries: a population-based systematic analysis of GLOBOCAN
|The Lancet. Gastroenterology & hepatology|2024|248